PFunding Rounds · Post-IPO
Pangaea Oncology — Post-IPO · €6.36M
In July 2024 shareholders approved a capital increase of up to 6,097,953 shares at €1.62 each (up to about €9.9M), offered without pre-emption rights to investors picked by the board. The result was announced on 9 August 2024: €6.358M raised to fund liquid-biopsy early-detection work. In the same month the company also received a €623K HaDEA grant for the SPACETIME project.
Lead unknown
RoundPost-IPO
Announced9 Aug 2024Not counted in totals
CityBarcelona
SectorHealthtech / Precision oncologySource
P
P
The company
Investors
No investors were disclosed for this round.